OMRF’s Dr. Jacquelyn Gorman receives $1M DoD grant to study gene variant linked to lupus, aiming to improve early detection ...

A novel antibody-based drug targeting the CD40 ligand helped close to half of patients with treatment-refractory systemic ...

A small-molecule oral drug shaping up as a first-in-class to treat various forms of lupus performed well in a phase II trial, ...

Belimumab is now the first and only subcutaneous biologic therapy approved for at-home administration in pediatric lupus nephritis.

Katlyn Lenz-Zanis (left), of Burgettstown, with Dr. Jaime Miller, of Highland Park. Both women have lupus and lead Pittsburgh Lupus Support Group, a chapter of the Lupus Foundation of America.

GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved a 200 mg/mL autoinjector ...

Dapirolizumab pegol, a novel CD40L inhibitor, is superior to placebo for achieving low disease activity and remission in ...

One year of treatment with dapirolizumab pegol reduced fatigue and disease activity in people with SLE in a Phase 3 trial.

They plan to continue doing this with their MCW Lupus Group, which meets at the Bay Shore-Brightwaters Public Library every fourth Wednesday of the month. There, ...

LIMA — The Lupus Foundation of America’s Greater Ohio Chapter will host a free information and support group event at 6:30 p.m. Monday, June 9 at the Lima Public Library, 650 W. Market St, Lima.